Chen C - Search Results

1

PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.

Wu Y, Wang Z, Han L, Guo Z, Yan B, Guo L, Zhao H, Wei M, Hou N, Ye J, Wang Z, Shi C, Liu S, Chen C, Chen S, Wang T, Yi J, Zhou J, Yao L, Zhou W, Ling R, Zhang J. Wu Y, et al. Among authors: chen c, chen s. Mol Ther. 2022 Jul 6;30(7):2603-2617. doi: 10.1016/j.ymthe.2022.03.003. Epub 2022 Mar 10. Mol Ther. 2022. PMID: 35278676 Free PMC article.

2

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.

Liu R, Shi P, Nie Z, Liang H, Zhou Z, Chen W, Chen H, Dong C, Yang R, Liu S, Chen C. Liu R, et al. Among authors: chen c, chen w, chen h. Theranostics. 2016 Feb 13;6(4):533-44. doi: 10.7150/thno.14315. eCollection 2016. Theranostics. 2016. PMID: 26941846 Free PMC article.

3

Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer.

Lin Y, Liu R, Zhao P, Ye J, Zheng Z, Huang J, Zhang Y, Gao Y, Chen H, Liu S, Zhou J, Chen C, Chen H. Lin Y, et al. Among authors: chen c, chen h. Eur J Med Chem. 2018 Feb 25;146:354-367. doi: 10.1016/j.ejmech.2018.01.056. Epub 2018 Feb 4. Eur J Med Chem. 2018. PMID: 29407962

4

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis.

Liu R, Chen H, Zhao P, Chen CH, Liang H, Yang C, Zhou Z, Zhi X, Liu S, Chen C. Liu R, et al. Among authors: chen ch, chen c, chen h. Int J Biol Sci. 2020 Jan 1;16(4):611-619. doi: 10.7150/ijbs.39491. eCollection 2020. Int J Biol Sci. 2020. PMID: 32025209 Free PMC article.

5

Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.

Wang X, Qiu T, Wu Y, Yang C, Li Y, Du G, He Y, Liu W, Liu R, Chen CH, Shi Y, Pan J, Zhou J, Jiang D, Chen C. Wang X, et al. Among authors: chen ch, chen c. Cell Death Differ. 2021 Oct;28(10):2931-2945. doi: 10.1038/s41418-021-00793-0. Epub 2021 May 10. Cell Death Differ. 2021. PMID: 33972717 Free PMC article.

6

Can EGFR be a therapeutic target in breast cancer?

Li X, Zhao L, Chen C, Nie J, Jiao B. Li X, et al. Among authors: chen c. Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188789. doi: 10.1016/j.bbcan.2022.188789. Epub 2022 Sep 3. Biochim Biophys Acta Rev Cancer. 2022. PMID: 36064121 Review.

7

Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.

Chen W, Zhang L, Liu S, Chen C. Chen W, et al. Among authors: chen c. Cells. 2022 Sep 20;11(19):2941. doi: 10.3390/cells11192941. Cells. 2022. PMID: 36230903 Free PMC article. Review.

8

METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions.

Li Y, He X, Lu X, Gong Z, Li Q, Zhang L, Yang R, Wu C, Huang J, Ding J, He Y, Liu W, Chen C, Cao B, Zhou D, Shi Y, Chen J, Wang C, Zhang S, Zhang J, Ye J, You H. Li Y, et al. Among authors: chen j, chen c. Nat Commun. 2022 Oct 26;13(1):6350. doi: 10.1038/s41467-022-34209-5. Nat Commun. 2022. PMID: 36289222 Free PMC article.

9

Targeting Breast Cancer Stem Cells.

Zhang L, Chen W, Liu S, Chen C. Zhang L, et al. Among authors: chen c, chen w. Int J Biol Sci. 2023 Jan 1;19(2):552-570. doi: 10.7150/ijbs.76187. eCollection 2023. Int J Biol Sci. 2023. PMID: 36632469 Free PMC article. Review.

10

LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2.

Zhao J, Xu J, Wu M, Wang W, Wang M, Yang L, Cai H, Xu Q, Chen C, Lobie PE, Zhu T, Han X. Zhao J, et al. Among authors: chen c. Int J Mol Sci. 2023 May 23;24(11):9157. doi: 10.3390/ijms24119157. Int J Mol Sci. 2023. PMID: 37298108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86,273 results

Search Page